Specialty pharmaceutical formulation platform using novel low‑concentration polymers to reformulate poorly soluble marketed drugs and solubilize/stabilize new chemical entities, improving bioavailability, safety and therapeutic index. Targets pharmaceutical developers and research institutions seeking enhanced API performance and additional patent protection.